ClinicalTrials HQ

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Active, not recruiting · NCT02736656 · Registry updated 2026-07-15
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)attention deficit hyperactivity disorder, inattentive type, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorderActive, not recruitingPhase 32026-07-15NCT02736656

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Supernus Pharmaceuticals, Inc.9

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alliance for Wellness dba Alliance for ResearchLong BeachUnited States1
Bayou City Research CorporationHoustonUnited States1
Clinical Neuroscience Solutions, Inc.MemphisUnited States7
CNS HealthcareMemphisUnited States4
Ericksen Research & DevelopmentClintonUnited States1
Florida Clinical Research Center, LLCMaitlandUnited States1
Florida Clinical Research Center, LLC.MaitlandUnited States1
Indago Research & Health Center, Inc.HialeahUnited States2
IPS ResearchOklahoma CityUnited States1
MCB Clinical Research Centers, LLCColorado SpringsUnited States1
Meridien Research at Florida Clinical Research CenterBradentonUnited States1
Northwest Clinical TrialsBellevueUnited States1
Paradigm Research ProfessionalsOklahoma CityUnited States1
Road Runner ResearchSan AntonioUnited States1
Sarkis Clinical TrialsGainesvilleUnited States9
Woodland International Research GroupLittle RockUnited States14